
Please try another search
Investing.com -- Sanofi (EPA:SASY) shares fell more than 2% on Thursday after the pharmaceutical and healthcare company reported second-quarter profit that came in below expectations, even as sales...
Investing.com -- Sanofi SA (EPA:SASY) announced Friday that its drug Sarclisa has received approval in the European Union for the treatment of transplant-eligible newly diagnosed multiple myeloma. The...
Investing.com -- French pharmaceutical company Sanofi (EPA:SASY) has agreed to purchase U.K.-based vaccine developer Vicebio in a deal worth up to $1.6 billion, the company announced Tuesday. The...
Investing.com -- The Food and Drug Administration (FDA) has granted orphan drug designation to Rilzabrutinib, a drug developed by Sanofi (NASDAQ:SNY) SA (EPA:SAN) for the treatment of sickle cell...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review